Navigation Links
Seaweed yields new compounds with pharmaceutical potential

Myers Squibb is collaborating with Georgia Tech researchers to determine how some of these 10 compounds kill cancer cells. Meanwhile, Georgia Tech has filed a provisional patent to protect the discovery of these structures and small variations of them.

"These molecular structures are curious in the way carbon atoms are attached," Kubanek said. "It's very unusual. They represent a new category of organic molecules. It's exciting as a biochemist to observe that living organisms have evolved the ability to synthesize such unique and exotic structures compared to other molecules typically produced by seaweeds."

The source of these new molecular structures is a red seaweed (Callophycus serratus) collected from four Fijian sites. Among the sites, researchers found variations in the molecular structures produced by the species.

"There are chemical differences among populations of this seaweed species, even though two of the sites where it was collected are only about 2 kilometers apart," Kubanek noted. "? This shows us there are small, but valuable differences within species, and this genetic biodiversity is important to protect as a resource for the future." Researchers have been analyzing extracts from about 200 marine plant and invertebrate animal samples they collected from the Fijian coral reef in June 2004 with the permission of the Fijian government and local resource owners.

"Marine organisms make molecules for their own purposes that we might co-opt for our own use as pharmaceutical agents," Kubanek explained. "The organisms' purposes include defense against predators, the ability to fight diseases, and the production of chemical cues, such as those used for sex recognition."

Hay, Kubanek, and their colleagues collected baseball-sized samples of reef species that exhibit unusual growth and/or behavioral phenomena. Among their collection were soft corals, marine sponges, slugs, and green, red and brown seaweeds.


'"/>

Source:Georgia Institute of Technology Research News


Page: 1 2 3 4

Related biology news :

1. Seaweed could make junk food healthier
2. Genome-wide mouse study yields link to human leukemia
3. Marine sponge yields nanoscale secrets
4. Small worm yields big clue on muscle receptor action
5. Organic farms produce same yields as conventional farms
6. GM crop that holds on to its seeds offers higher yields
7. Computer-chemistry yields new insight into a puzzle of cell division
8. Infection alarm yields clues to immune system behavior
9. BiovaxID?yields 89 percent survival in patients with aggressive non-Hodgkins
10. A clue from macaques yields evidence for impaired retroviral defense genes in humans
11. Food-crop yields in future greenhouse-gas conditions lower than expected
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Seaweed yields new compounds with pharmaceutical potential

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
(Date:3/20/2015)... March 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... one of the products featured in 2015 "I Want ... 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 International ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... invented a device to reduce the risk of infection, clotting ... blood-cleansing dialysis because of kidney failure. The device, designed ... would give a technician easy access to the patient,s bloodstream ... and end of a dialysis procedure. The prototype has ...
... that could stop the virus in its tracks have come ... Leeds, UK. The study by Dr Stephen Griffin and ... two prototype small molecule drugs, known as p7 inhibitors, can ... findings suggest that p7 inhibitors could be a powerful way ...
... doughnut-shaped laser is the latest marvel of silicon microminiaturization, but ... particles play a big and largely unnoticed role ... particles trigger cloud formation, and soot particles sift deep into ... sensor belongs to a category called whispering gallery resonators, which ...
Cached Biology News:Student team invents device to cut dialysis risk 2Will new drugs block hepatitis C virus in its tracks? 2Tiny ring laser accurately detects and counts nanoparticles 2Tiny ring laser accurately detects and counts nanoparticles 3Tiny ring laser accurately detects and counts nanoparticles 4Tiny ring laser accurately detects and counts nanoparticles 5
(Date:3/31/2015)... , March 31, 2015  University of ... will deliver the plenary session address on Monday, ... Microwave Symposium (IMS) , kicking off a week of ... at the intersection of RF and microwave technologies with ... of Radios, Sensors and Circuits for the Skin," will ...
(Date:3/30/2015)... San Francisco, CA (PRWEB) March 30, 2015 ... and tax incentives provided you the government, major companies ... state and local governments setting future mandates for renewable ... power as an option. , Solara Power is a ... to several incentive programs available that allow qualifying homeowners ...
(Date:3/30/2015)... BRUNSWICK, N.J. , March 30, 2015  New ... and innovation projects in the state of ... its next round of grant funding, announced James ... New Jersey Health Foundation Research Grants program, an additional ... $35,000 each to fund early stage research projects that ...
(Date:3/30/2015)...  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... monetization of intellectual property, today provided an update ... Spherix v. Uniden , Case No. 3:13-cv-03496-M, both ... Northern District of Texas ... Case No. 1:14-cv-00721-GBL-TCB, in the United States ...
Breaking Biology Technology:Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Solara Power Announces Residential Solar Power with No Up-Front Fees 2New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... , CHICAGO, Aug. 3 Known ... dry, itchy skin and rashes.(1) Scratching the affected ... cracking, weeping of clear fluid, and crusting of the ... be effective treatments for patients with mild, moderate or ...
... Md., Aug. 3 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... from the European Medicines Agency (EMEA) for BiTE antibody ... is a novel therapeutic antibody that activates a patient,s ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) ... to long-term treatment with Stimuvax were presented at the ... World Conference on Lung Cancer in San Francisco on ... from the Ottawa Hospital Cancer Centre, Ottawa, Ontario, involved ...
Cached Biology Technology:Five Questions About Protopic (tacrolimus) Ointment 2Five Questions About Protopic (tacrolimus) Ointment 3Five Questions About Protopic (tacrolimus) Ointment 4Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 4Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer 2Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer 3Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer 4
...
...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid...
... moderate chemiluminescence efficiencies and the chemistry of ... the added benefit that they require simple ... background signal. This benefit has been exploited ... applications. These compounds can also be easily ...
Biology Products: